Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CDS+ cytotoxic T lymphocytes

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 577-584

  Tsai, Sun Lung ^a   Chen, Ming Huei ^a   Yeh, Chau Ting ^a   Chu, Chia Ming ^a   Lin, Ae Ning ^b   Chiou, Fu Horng ^b   Chang, Tong Hsuan ^b   Liaw, Yun Fan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b DEVELOPMENT CENTER FOR BIOTECHNOLOGY   (Taiwan)

Author keywords

Hepatitis B virus; Hepatocytolysis; Mutation clustering region; Naturally occurring peptide; T cell epitope

Indexed keywords

CD8 ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ANTIGEN EXPRESSION; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; SENSITIZATION; VIRUS GENOME;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; HEPATITIS B ANTIGENS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HLA-A ANTIGENS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030045482     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118450     Document Type: Article

References (45)

1. Beasley. R. P., L. Y. Hwang. C. C. Lin, and C. C. Chien. 1981 Hepatocellular carcinoma and hepatitis B virus. Lancet. 11:1129-1133.
2. Chen, D. S. 1993. From hepatitis to hepatoma, lessons learned from type B hepatitis. Science (Wash. DC) 262:369-370
3. Peters, M., J. Vierling, M. E. Gershwin, D. R. Milich, F. V Chisari, and J H. Hoofnagle 1991. Immunology and liver. Hepatology. 13:977-994.
4. Chisari, F. V , and C. Ferrari. 1995 Hepatitis B virus immunopathogenesis. Annu. Rev Immunol. 13:29-60.
5. Bertoletti, A . C. Ferrari, F. Fiaccadori, A. Penna, R. Margolskee, H. J. Schlicht. P Fowler, S. Guilhot, and F. V. Chisan. 1991. HLA class 1-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl Acad Sci. USA 88 10445-10449.
6. Penna, A., F. V. Chisari, A Bertoletti, G Missale. P. Fowler, T. Giuberti, F. Fiaccadori, and C Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restnctcd epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med 174:1565-1570.
7. Guilhot, S., P. Fowler, G Portillo. R. F. Margolskee, C Ferrari. A. Bertoletti, and F. V Chisari. 1992. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J. Virol. 66:2670-2678.
8. Kamogawa, Y., K. Yamauchi, H. Obata, O Chisaka, and K. Matsubara. 1992. Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients. Virology. 191:321-326.
9. Missale, G., A. Redeker, J Person, P. Fowler, S. Guilhot, H.-J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLA-Aw68-restricted T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med. 177:751-762.
10. Lohr, H.F., G. Gerken, H.-J. Schlicht. K.-H. Meyer zum Büschenfelde. and B Fleischer 1993. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B J. Infect. Dis. 168:1133-1139.
11. Nayersina, R., P. Fowler, S. Guilhot. G. Missale. A. Cerny, H.-J. Schlicht, A. Vitiello, R Chesnut, J. L. Person, A. G. Redeker. and F V. Chisari 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150: 4659-4671.
12. Hecke, E. V., J. Paradijs, C. Molitor, C. Bastin, P. Pala, M Slaoui, and G Leroux-Roels. 1994. Hepatitis B virus-specific cytotoxic T lymphocyte responses in patients with acute and chronic hepatitis B virus infection. J Hepatol 20 514-523
13. Hsu, H. C., I J. Su, M. Y. Lai, D. S. Chen, M. H. Chang, S M. Chuang, and J. L. Sung. 1987. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J. Hepatol. 5:45-50.
14. Chu, C. M., and Y. F. Liaw. 1987. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection: hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis Gastroenterology. 92:220-225.
15. Tsai, S L., P. J. Chen, M. Y. Lai, P. M Yang, J. L. Sung, J. H. Huang, L H. Hwang, T. H. Chang, and D. S. Chen 1992 Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens: implications for hepatitis B e antigen seroconversion J Clin Invest. 89:87-96.
16. Chu, C. M., W. C. Shyu, R W Kuo, and Y. F. Liaw. 1987. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis Hepatology. 7:1311-1316
17. Rotzschke, O., and K Falk. 1991. Naturally occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol Today 12:447-455.
18. Chicz, R. M., and R G. Urban. 1994. Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development. Immunol. Today. 15:155-160.
19. Joyce, S., and S. G. Nathenson. 1994. Methods to study peptides associated with MHC class I molecules. Curr Opin Immunol 6:24-31.
20. Ozols, J 1990. Preparation of membrane fractions Methods Enzymol. 182.225-235.
21. Udaka, K , T. J Tsomides, and H. N. Eisen. 1992. A naturally occurring peptide recognized by alloreactive CDS+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989-998.
22. Ou, J. H., O. Laub, and W. J. Rutter. 1986. Hepatitis B virus gene function, the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc. Natl Acad. Sci USA. 83:1578-1582.
23. Yeh, C T., S. W. Wong, Y. K Fung. and J.-H. Ou. 1993. Cell cycle regulation of nuclear localization of hepatitis B virus core protein Proc. Natl. Acad. Sci. USA. 90.6459-6463.
24. Tsai, S. L., D. S. Chen, and T. H. Chang. 1994. Peptide recognition and competition, T cell receptor usage, and HLA restriction elements of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis. In Viral Hepatitis and Liver Disease. K. Nishioka, H. Suzuki. S. Mishiro, and T Oda, editors. Springer-Verlag, Tokyo. 162-167.
25. Tsai, S. L., P. M. Yang, T. H. Liao, J. L. Sung, M. Y. Lai, J. H Huang T. H. Chang, and D. S. Chen 1994. Characterization of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis: implication for a T cell mechanism of HBV immunopathogenesis. J. Biomed. Sci. 1:105-118.
26. Ljunggren, H.-G., N. J Stam, C. Ohlén, J. J. Neefjes, P. Hoglund, M -T. Heemels, J. Bastin, T. N M. Schumacher, A. Townsend, K. Kärre, and H. L. Ploegh. 1990. Empty MHC class I molecules come out in the cold Nature (Lond.). 346:476-480.
27. Schumacher, T. N. M , M.-T. Heemels, J. J. Neefjes, W. M. Kast, C T. M. Melief, and H. L. Ploegh 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62.563-567.
28. Townsend, A., C. Ohlén, J. Bastin, H.-G. Ljunggren, L. Foster, and K. Karre. 1989 Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond.). 340:443-448.
29. Vitiello, A., T A. Potter, and L A. Sherman. 1990. The role of β2-microglobulin in peptide binding by class I molecules. Science (Wash. DC) 250: 1423-1426.
30. Kozlowski, S., T. Takeshita, W.-H Boehncke, H. Takahashi, L. F. Boyd, R. N. Germain, J. A. Berzofsky, and D. H. Margulies. 1991. Excess β2-microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature (Lond.). 349:74-77.
31. Silver, M. L., K. C. Parker, and D. C Wiley. 1991. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with β2-microglobulin in vitro. Nature (Lond.). 350:619-622.
32. Cerny, A., J. G McHutchison, C. Pasquinelli, M. E. Brown, M A. Brothers, B. Grabscheid, P Fowler, M. Houghton, and F C. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521-530.
33. Nijman, H. W., J. G. A. Houbiers, M. P. M Vierboom, S. H. Van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. M. Melief, and M. Kast 1993 Identification of peptide sequences that potentially trigger HLA-A2 1 restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23:1215-1219.
34. Zeh, H. J., III, G. H Leder, M. T. Lotze, R. D. Salter, M. Tector, G. Stuber. S. Modrow, and W J. Storkus. 1994. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum. Immunol. 39:79-86.
35. + cytotoxic T lymphocytes. J Exp. Med. 181:363-368
36. Barnaba, V., A Franco, A. Alberti, C. Balsano, R. Benvenuto, and F. Balsano. 1989 Recognition of hepatitis B virus envelope proteins by liver infiltrating T lymphocytes in chronic HBV infection. J Immunol. 143:2650-2655.
37. Barnaba, V., A. Franco, A. Alberti, R. Benvenuto, and F. Balsano. 1990. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature (Lond.). 345: 258-260.
38. Townsend, A. R. M., J. Rothbard, F. M Gotch, G. Bahadur, D. Wraith, and A. J. MeMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:959-968.
39. Bertoletti, A., A. Sette, F. V. Chisari, A Penna. M. Levrero, M De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (Lond.) 369:407-410.
40. Milich, D. R. 1991. Immune response to hepatitis B virus proteins: relevance of the murine model. Semin. Liver Dis. 11:93-112.
41. Oldstone, M. B. A 1989. Viral persistence. Cell. 56:517-520.
42. Koup, R. A. 1994. Virus escape from CTL recognition J. Exp. Med 180: 779-782
43. Chuang, W -L , M. Omata, T. Ehata, O. Yokosuka, Y. Ito, F. Imazeki, S.-N. Lu, W -Y Chang, and M. Ohio. 1993. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 104:263-271
44. Ehata, T , M. Omata, O. Yokosuka, K Hosoda, and M. Ohto. 1991. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin. Invest. 89: 332-338
45. de Campos-Lima, P. O , V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp. Med. 179:1297-1305.